This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Spinal cord
CD2_BENIGN_SPINAL_CORD_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum medullae spinalis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Spinal cord
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Spinal cord
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 500 | 271 | 229 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 54.11 | 53.44 | 54.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 450
- Matched controls
- 4499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
286.0
243
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
3081.4
201.9
180
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
81.8
76
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
74.0
69
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
20.9
74.0
113
71
D33.43
ICD-10 Finland
Spinal cord
+∞
72.9
68
*
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
70.7
66
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
70.7
66
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
299.5
53.4
53
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
62.7
52.1
60
11
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
49.9
47
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
33.4
43.0
56
19
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.7
41.6
138
326
H02AB02
ATC
dexamethasone; systemic
39.1
39.0
49
14
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
+∞
37.0
35
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
34.8
33
*
N03AX16
ATC
pregabalin; oral
3.9
32.7
171
616
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
30.6
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
30.2
169
636
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.3
27.6
92
209
N03AX12
ATC
gabapentin; oral
4.1
27.5
123
377
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
27.0
25.7
35
14
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
24.3
25.6
36
16
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.9
25.4
75
147
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
22.9
25.2
36
17
N02AX02
ATC
tramadol; systemic, rectal
2.9
24.4
235
1246
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
24.2
23
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
91.8
23.9
26
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
23.1
22
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
11.4
21.3
40
38
130
Kela drug reimbursment
Malignant tumour
+∞
21.0
20
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
21.0
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
219.7
20.8
21
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
19.9
19
*
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
19.9
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
19.9
19
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.6
18.5
56
112
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
22.9
18.4
26
12
WX402
NOMESCO Finland
General anaesthesia
3.4
17.9
97
338
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.8
17
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.6
17.7
53
105
SPAT1153
SPAT
Removal of sutures
2.6
17.3
169
856
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
16.8
16
*
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
93.6
16.7
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
16.1
110
445
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
15.7
15
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
15.7
15
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
88.2
15.7
17
*
N02AA05
ATC
oxycodone; systemic
3.8
15.4
68
200
R4110
NOMESCO Finland
Physiotherapy
2.5
15.0
139
672
N02BE01
ATC
paracetamol; systemic, rectal
2.9
15.0
397
3229
Z31.5
ICD-10 Finland
Genetic counselling
6.6
14.8
38
62
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
14.7
14
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
154.8
14.5
15
*
M03BX01
ATC
baclofen; systemic
11.0
14.4
27
26
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
14.2
56
148
WF002
NOMESCO Finland
Radical radiotherapy
55.1
13.9
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
13.6
13
*
AA1AD
NOMESCO Finland
CT of head and brain
2.5
13.6
127
614
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.6
13.3
34
55
L28
ICPC
Limited function/disability (L)
2.9
13.3
92
371
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
13.3
57
163
XKD00
NOMESCO Finland
Uroflowmetry
3.0
13.0
81
306
S18
ICPC
Laceration/cut
2.2
13.0
197
1193
UKC02
NOMESCO Finland
Cystoscopy
3.0
12.8
77
286
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
71.9
12.7
14
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
12.6
12
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
12.4
57
173
ZXC40
NOMESCO Finland
Use of ultrasound
27.6
12.1
16
6
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.9
12.0
20
15
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
12.0
60
195
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
M54.5
ICD-10 Finland
Low back pain
2.1
11.5
165
964
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
123.0
11.5
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
11.5
73
280
NK6AN
NOMESCO Finland
Total body bone isotope imaging
36.0
11.3
14
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
44.5
11.0
13
*
D33.30
ICD-10 Finland
Acoustic neuroma
18.4
10.8
16
9
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
10.6
28
48
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
10.5
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
10.5
10
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
10.1
63
238
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
10.1
190
1224
WX110
NOMESCO Finland
Local anesthesy
2.0
10.0
316
2457
JN4BD
NOMESCO Finland
Extensive body CT
4.6
9.9
34
79
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
5.4
9.9
29
57
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.6
9.5
42
124
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
18.0
9.5
14
8
ZX090
NOMESCO Finland
Other technic of radiotherapy
102.1
9.4
10
*
A04AA02
ATC
granisetron; systemic, transdermal
102.1
9.4
10
*
ZZR00
NOMESCO Finland
Flap of skin
30.7
9.4
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.6
9.4
32
74
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
9.4
9
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
9.4
9
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
9.4
9
*
M48.0
ICD-10 Finland
Spinal stenosis
2.7
9.3
67
275
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
9.0
66
276
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
9.0
134
784
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
51.0
8.7
10
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.7
8.6
60
240
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
8.6
79
369
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
28.1
8.5
11
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
28.1
8.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
5.0
8.5
26
54
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.5
8.5
12
6
A06AD11
ATC
lactulose; oral
2.6
8.5
66
284
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.3
8.5
30
73
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
+∞
8.4
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
+∞
8.4
8
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
8.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
8.3
138
836
N06AX21
ATC
duloxetine; oral
2.6
8.2
61
254
TAB00
NOMESCO Finland
Lumbar puncture
4.2
8.2
30
75
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
12.0
8.1
14
12
G82.2
ICD-10 Finland
Paraplegia, unspecified
17.6
8.1
12
7
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
34.0
8.1
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
8.0
168
1102
M54.2
ICD-10 Finland
Cervicalgia
3.2
8.0
41
137
JN4AD
NOMESCO Finland
Body CT examination
5.0
7.9
24
50
R4120
NOMESCO Finland
Occupational therapy
3.2
7.6
38
125
WF004
NOMESCO Finland
Palliative radiotherapy
81.4
7.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
81.4
7.4
8
*
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
81.4
7.4
8
*
2312
FHL
Extirpation or destruction
81.4
7.4
8
*
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
N76
ICPC
Neoplasm nervous system unspecified
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
N75
ICPC
Benign neoplasm nervous system
+∞
7.3
7
*
ZXA05
NOMESCO Finland
Left side
1.9
7.3
112
656
R33
ICD-10 Finland
Retention of urine
3.0
7.3
41
145
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
7.2
26
65
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
30.5
7.2
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
7.2
31
91
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
7.1
84
440
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
7.1
57
248
M03BX02
ATC
tizanidine; oral
1.7
7.1
275
2154
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
7.0
28
77
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
6.8
17
28
N18
ICPC
Paralysis/weakness
5.8
6.8
18
32
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
9.5
6.8
13
14
N06AA09
ATC
amitriptyline; systemic
2.5
6.8
53
229
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
40.7
6.8
8
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
17.0
6.8
10
6
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
6.8
63
298
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.6
6.7
16
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.6
124
777
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
6.5
39
145
A02BC02
ATC
pantoprazole; systemic
1.7
6.5
271
2137
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
70.8
6.4
7
*
L03
ICPC
Low back symptom/complaint
1.9
6.4
110
667
B01AB05
ATC
enoxaparin; parenteral
1.8
6.3
116
719
G04BE03
ATC
sildenafil; oral
18.3
6.3
9
5
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
6.3
6
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.2
6.2
18
36
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
6.2
20
45
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
6.2
46
194
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
6.1
108
658
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.1
156
1068
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
12.7
6.1
10
8
N28
ICPC
Limited function/disability (N)
6.8
6.1
14
21
R52.2
ICD-10 Finland
Other chronic pain
4.1
6.1
22
56
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
47
26
19.85
59.28
1.6
3.4
—
—
—
0
0
120
384
3.80
32.34
8.6
9.0
1.5
1.4
mmol/l
0.13
94
301
289
1606
2.89
29.74
7.1
5.4
1.2
1.2
mmol/l
0.47
274
1429
294
1668
2.85
28.75
4.2
3.6
—
—
—
0
0
305
1780
2.83
27.97
8.2
5.9
1.2
1.2
mmol/l
0.71
274
1538
182
816
2.93
27.65
2.2
2.0
—
—
—
0
0
341
2294
2.53
20.59
6.4
4.4
6.4
6.7
mmol/l
1.89
323
2119
65
210
3.41
16.73
11.8
9.9
1.4
1.5
%
0.47
65
210
64
206
3.42
16.56
11.9
10.0
0.7
0.7
%
0.23
64
206
220
1312
2.21
16.33
3.9
2.9
—
—
—
0
0
241
1513
2.14
15.46
5.3
3.6
35.7
36.2
g/l
0.65
227
1407
340
2482
2.16
14.15
6.4
4.0
968.4
1218.6
e6/l
—
5
40
173
995
2.13
13.55
3.6
2.8
0.4
0.4
e6/l
0.05
144
738
122
615
2.30
13.21
2.8
2.5
0.7
1.0
e6/l
1.02
72
343
300
2129
2.02
12.97
9.3
6.8
4.1
4.2
e9/l
0.49
263
1867
15
17
9.07
12.06
1.9
1.2
—
—
—
0
0
105
522
2.28
11.62
3.7
3.0
0.8
0.8
mmol/l
0.53
100
484
111
570
2.22
11.34
3.0
2.7
1.7
2.5
e6/l
0.52
62
298
262
1855
1.87
10.55
7.7
3.9
10.3
11.2
umol/l
1.47
252
1734
20
37
5.59
10.48
2.0
1.2
—
—
—
0
0
372
2963
2.00
10.27
8.9
5.3
73.5
74.4
u/l
0.26
364
2729
187
1238
1.82
8.97
2.4
2.1
215.1
227.9
u/l
0.06
180
1166
178
1163
1.82
8.90
4.0
2.0
2.4
2.3
mmol/l
0.99
161
973
103
562
2.05
8.84
1.7
1.9
30.2
29.5
s
0.32
103
543
50
205
2.60
8.36
1.6
1.5
—
—
—
0
0
461
4086
2.64
8.29
19.0
11.3
21.6
21.7
mg/l
0.02
384
3073
85
445
2.10
8.11
4.8
5.1
1.0
1.0
mmol/l
0.08
79
401
154
1001
1.78
7.63
5.1
3.5
0.0
0.0
estimate
0.50
49
320
259
1946
1.69
7.56
4.8
3.4
0.0
0.0
estimate
0.50
46
318
46
191
2.55
7.50
4.2
1.4
3.7
4.3
ug/l
0.10
36
147
365
3031
1.76
7.13
4.5
4.0
10.0
10.8
mm/h
0.64
343
2784
254
1919
1.66
7.10
4.5
3.4
0.0
0.0
estimate
0.00
44
329
92
533
1.89
6.53
6.5
6.0
—
—
—
0
0
250
1916
1.61
6.35
5.7
4.7
0.0
0.0
estimate
0.00
48
327
13
26
5.11
6.25
1.8
1.2
2.6
1.7
mmol/l
1.34
13
26
218
1623
1.61
6.20
2.4
2.2
77.7
77.0
nmol/l
0.12
205
1433
104
641
1.79
6.03
3.3
2.0
2.4
2.4
mmol/l
1.16
90
553
205
1553
1.54
5.16
3.6
3.4
24.6
60.6
ng/l
0.88
133
1057
16
46
3.56
4.93
1.4
1.2
—
—
—
0
0
365
3173
1.56
4.57
4.6
3.8
14.8
14.8
pmol/l
0.20
333
2903
170
1266
1.52
4.50
4.0
2.8
35.8
31.2
u/l
0.52
165
1208
23
88
2.69
4.46
1.6
1.6
—
—
—
0
0
128
912
1.54
4.10
2.3
2.1
3.1
3.0
mg/l
0.11
107
763
40
206
2.02
4.00
1.8
1.6
—
—
—
0
0
149
1104
1.50
3.96
3.0
2.9
947.1
1044.6
ng/l
0.17
120
931
58
346
1.77
3.73
4.0
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
91
2.48
3.69
1.9
2.7
0.4
0.4
u/ml
—
9
50
19
75
2.59
3.50
1.2
1.2
—
—
—
0
0
84
568
1.58
3.36
2.3
1.8
—
—
—
0
0
102
725
1.51
3.26
1.4
1.3
21.7
35.6
iu/ml
1.33
29
226
158
1225
1.42
3.23
3.5
2.2
51.8
58.3
u/l
2.03
147
1127
418
3840
1.54
3.19
5.5
4.5
1.8
2.2
mu/l
0.62
384
3527
124
928
1.45
3.05
1.5
1.5
21.6
21.2
nmol/l
0.11
109
794
186
1502
1.38
2.95
4.9
3.4
—
—
—
0
0
121
908
1.44
2.93
5.8
3.5
1.0
1.0
kg/l
0.47
16
136
51
319
1.67
2.80
2.0
1.9
96.1
69.2
ml/min/173m2
0.42
19
130
421
3901
1.50
2.79
16.1
10.0
85.9
82.7
ml/min/173m2
2.02
372
3117
48
299
1.67
2.68
3.0
3.1
151.5
159.9
ng/l
0.07
42
274
48
301
1.66
2.62
2.7
2.5
23.3
20.5
au/ml
—
6
10
135
1054
1.38
2.58
4.8
3.6
20.1
23.7
%
2.06
74
453
113
857
1.41
2.56
1.7
1.8
1.1
1.0
mg/l
0.17
84
643
66
453
1.53
2.48
2.3
2.3
21.2
23.9
%
0.98
58
397
25
132
1.94
2.40
1.4
1.5
289.8
265.9
mu/l
0.31
25
120
207
1744
1.32
2.37
2.7
2.7
102.2
111.2
ug/l
0.44
192
1605
23
119
1.98
2.34
1.3
1.2
—
—
—
0
0
51
336
1.58
2.30
3.1
3.1
2.4
2.1
mmol/l
0.25
44
266
23
120
1.96
2.29
1.3
1.2
—
—
—
0
0
9
29
3.14
2.23
1.3
1.0
—
—
—
0
0
9
29
3.14
2.23
1.1
1.2
—
—
—
0
0
10
36
2.81
2.21
1.8
1.5
—
—
—
0
0
194
1632
1.31
2.21
2.1
1.9
93.3
95.7
pmol/l
0.32
105
843
416
3896
1.40
2.13
5.7
5.8
38.3
39.8
mmol/mol
3.42
391
3636
37
231
1.65
2.09
2.7
3.8
2.3
2.0
mmol/l
0.14
24
170
57
395
1.50
2.07
2.6
1.8
—
—
—
0
0
309
2779
1.29
2.06
4.1
3.0
46.0
44.4
u/l
0.20
303
2606
6
15
4.04
2.04
1.2
1.1
—
—
—
0
0
6
15
4.04
2.04
1.2
1.3
—
—
—
0
0
6
15
4.04
2.04
1.2
1.1
—
—
—
0
0
6
15
4.04
2.04
1.2
1.2
—
—
—
0
0
116
918
1.34
2.01
1.3
1.3
2.4
1.3
u/ml
0.28
34
255
482
4667
1.91
2.00
28.1
16.8
135.4
137.7
g/l
3.24
482
4592
297
2664
1.28
1.99
2.9
3.0
—
—
—
0
0
126
1011
1.33
1.99
3.1
2.4
344.2
7354.8
umol/l
4.19
114
885
12
51
2.39
1.96
1.4
1.1
—
—
—
0
0
56
392
1.48
1.95
2.6
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.58
1.94
1.8
3.8
103.8
94.6
%
—
5
11
48
327
1.52
1.90
3.6
2.1
31.8
34.4
u/l
0.16
42
266
12
52
2.34
1.89
1.2
1.1
—
—
—
0
0
91
701
1.36
1.87
1.3
1.3
3.3
11.4
u/ml
2.47
41
274
75
560
1.40
1.86
2.4
2.2
13.4
13.8
umol/l
0.19
69
516
10
40
2.53
1.84
1.1
1.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.0
—
—
—
0
0
8
30
2.69
1.73
2.0
1.6
—
—
—
0
0
67
501
1.39
1.66
2.2
2.2
2.3
2.4
g/l
0.45
62
467
462
4453
1.49
1.59
12.6
8.5
26.1
26.6
u/l
0.29
451
4281
7
26
2.72
1.58
2.3
1.9
—
—
—
0
0
156
1324
1.26
1.57
5.5
3.6
2.2
1.8
ug/l
0.89
140
1188
13
64
2.06
1.55
2.3
1.3
62.2
56.8
pmol/l
0.26
13
64
5
15
3.36
1.52
1.2
1.1
—
—
—
0
0
20
117
1.74
1.47
2.7
3.5
—
—
—
0
0
92
739
1.30
1.44
3.3
2.6
0.6
0.7
ug/l
0.60
66
463
6
22
2.75
1.44
16.8
9.5
0.6
0.6
mmol/l
—
6
22
9
39
2.33
1.43
1.1
1.3
—
—
—
0
0
9
40
2.27
1.40
5.6
4.6
—
—
—
0
0
11
53
2.10
1.39
1.4
1.1
—
—
—
0
0
18
104
1.76
1.38
2.4
1.7
4.5
6.0
iu/l
—
7
37
8
161
0.49
1.38
1.3
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.63
1.37
1.7
1.2
—
—
—
0
0
6
23
2.63
1.37
1.7
1.1
—
—
—
0
0
0
40
0.00
1.33
0.0
1.4
—
—
—
0
0
23
145
1.61
1.31
1.8
1.6
—
—
—
0
0
31
210
1.51
1.31
1.0
1.0
—
—
—
0
0
49
365
1.38
1.27
2.7
2.4
4.8
7.4
ug/l
0.78
44
323
9
44
2.06
1.27
1.3
1.1
—
—
—
0
0
24
155
1.58
1.25
1.3
2.2
—
—
—
0
0
31
213
1.49
1.24
1.3
1.3
—
—
—
0
0
33
230
1.47
1.23
1.4
1.4
—
—
—
0
0
11
56
1.99
1.23
1.0
1.1
8.5
1.5
u/ml
—
6
20
21
132
1.62
1.22
1.1
1.3
2.8
3.0
g/l
0.26
14
102
363
3423
1.22
1.20
22.2
13.7
13.7
13.6
%
1.10
357
3355
20
125
1.63
1.19
1.2
1.3
8.8
10.8
g/l
1.33
14
106
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
5
21
2.39
1.09
3.8
3.8
27.2
31.9
umol/l
—
5
14
21
137
1.56
1.07
1.1
1.3
6.4
7.4
g/l
2.33
14
104
21
137
1.56
1.07
1.1
1.3
—
—
—
0
0
21
137
1.56
1.07
1.1
1.3
3.2
3.8
g/l
2.36
14
100
12
68
1.78
1.01
1.2
1.6
—
—
—
0
0
426
4110
1.25
0.98
4.9
4.4
5.9
5.9
mmol/l
0.06
395
3765
18
116
1.57
0.98
1.3
1.1
4.8
12.9
u/ml
—
5
15
12
69
1.76
0.97
15.9
4.1
5.4
5.1
kpa
0.29
12
69
63
513
1.26
0.92
1.8
1.7
1.6
1.5
%
0.13
55
448
90
764
1.22
0.91
4.7
3.7
337.6
479.6
ng/l
0.25
74
571
39
299
1.33
0.89
1.3
1.2
83.7
121.6
iu/ml
0.37
14
128
8
42
1.92
0.89
1.1
1.0
—
—
—
0
0
13
79
1.66
0.88
2.5
2.8
8.6
8.0
kpa
0.58
13
74
65
535
1.25
0.87
4.8
4.5
31.4
31.8
%
0.13
50
357
20
137
1.48
0.85
1.9
1.6
—
—
—
0
0
13
81
1.62
0.82
1.4
1.2
—
—
—
0
0
12
75
1.61
0.75
1.8
1.5
—
—
—
0
0
5
24
2.09
0.74
3.8
1.3
15.6
14.6
ug/l
—
5
24
20
142
1.43
0.73
2.3
2.3
592.7
577.4
ug/l
0.01
20
131
9
56
1.62
0.72
2.0
1.5
—
—
—
0
0
11
68
1.63
0.72
1.8
1.4
—
—
—
0
0
11
68
1.63
0.72
1.8
1.4
—
—
—
0
0
19
135
1.42
0.70
1.5
1.7
—
—
—
0
0
10
61
1.65
0.69
1.0
1.1
3.0
4.3
u/ml
—
5
26
27
207
1.32
0.65
3.7
1.8
—
—
—
0
0
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
5
29
1.73
0.64
3.0
1.8
—
—
—
0
0
394
3816
1.15
0.63
20.9
12.4
39.4
40.6
%
1.55
282
2771
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
10
64
1.57
0.59
2.5
1.7
—
—
—
0
0
8
53
1.52
0.58
1.4
1.5
—
—
—
0
0
31
247
1.27
0.58
2.6
2.7
128.2
130.3
g/l
0.21
31
242
6
35
1.72
0.58
1.5
1.5
0.6
1.4
u/ml
—
6
20
6
36
1.67
0.57
1.2
1.1
—
—
—
0
0
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
5
88
0.56
0.56
1.2
1.5
—
—
—
0
0
10
65
1.55
0.56
2.5
1.7
—
—
—
0
0
10
65
1.55
0.56
2.1
1.5
—
—
—
0
0
34
415
0.81
0.55
1.6
1.8
—
—
—
0
0
18
135
1.35
0.51
1.4
1.4
—
—
—
0
0
14
101
1.40
0.50
1.3
1.1
—
—
—
0
0
7
46
1.53
0.48
1.9
1.6
—
—
—
0
0
91
825
1.13
0.44
1.5
1.6
83951051.7
7289067.0
pmol/l
0.44
81
686
13
95
1.38
0.44
1.3
1.2
—
—
—
0
0
6
92
0.65
0.42
1.5
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.4
1.1
1.0
g/l
—
5
34
0
18
0.00
0.40
0.0
1.1
—
8.8
—
0
18
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
8
61
1.32
0.39
1.0
1.1
—
—
—
0
0
10
71
1.42
0.39
1.1
1.3
—
—
—
0
0
433
4257
1.13
0.38
5.2
4.9
2.7
2.8
mmol/l
0.24
405
3945
78
708
1.12
0.38
1.7
1.7
1304.6
1203.7
nmol/l
0.21
61
536
6
43
1.40
0.35
1.7
1.5
—
—
—
0
0
10
73
1.38
0.34
1.4
1.7
—
—
—
0
0
120
1124
1.09
0.33
2.0
1.6
1.4
1.4
mmol/l
0.06
108
953
29
248
1.18
0.32
3.7
1.9
—
—
—
0
0
7
52
1.35
0.31
1.0
1.0
—
—
—
0
0
19
158
1.21
0.28
1.6
1.6
—
—
—
0
0
424
4185
1.09
0.25
4.7
4.5
4.6
4.7
mmol/l
0.18
400
3895
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
12
97
1.24
0.23
1.3
1.6
4255.1
10255.3
e6/l
—
7
70
5
42
1.19
0.21
2.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
6
48
1.25
0.20
2.0
1.7
—
—
—
0
0
6
49
1.23
0.20
3.0
2.6
—
548.1
u/ml
—
0
7
137
1325
1.05
0.15
3.3
3.1
7.7
7.8
mmol/l
0.10
119
1113
64
606
1.06
0.15
1.5
1.4
—
—
—
0
0
133
1291
1.04
0.13
3.5
4.0
3.9
8.1
mg/mmol
1.82
90
807
405
4017
1.04
0.11
4.2
4.0
1.3
1.3
mmol/l
0.60
376
3693
12
105
1.15
0.11
1.2
1.2
—
9.5
—
0
9
419
4160
1.04
0.11
4.7
4.4
1.5
1.5
mmol/l
0.05
392
3850
5
47
1.06
0.09
1.6
1.1
—
—
—
0
0
5
62
0.80
0.08
1.0
1.2
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
10
88
1.14
0.08
2.0
1.7
—
—
—
0
0
52
500
1.04
0.08
31.6
22.0
1.4
1.2
inr
—
8
73
47
488
0.96
0.07
3.1
2.0
—
—
—
0
0
12
111
1.08
0.04
1.3
1.3
—
—
—
0
0
73
741
0.98
0.02
1.7
1.5
—
—
—
0
0
43
439
0.98
0.02
2.9
1.8
—
—
—
0
0
10
93
1.08
0.02
2.7
2.7
25.6
25.2
mmol/l
—
10
82
20
194
1.03
0.00
3.1
2.5
25.6
25.3
mmol/l
0.17
20
186
11
109
1.01
0.00
1.1
1.2
—
—
—
0
0
12
121
0.99
0.00
1.7
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
0.00
8.4
5.5
416.7
377.8
umol/l
—
7
65
6
61
0.98
0.00
1.5
1.8
—
—
—
0
0
12
120
1.00
0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SPINAL_CORD_EXALLC – Benign neoplasm: Spinal cord
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).